MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/mrd-guided-azacitidine-may-delay-relapse-aml-mds-2026a1000a15?src=rss

Author :

Publish date : 2026-04-02 09:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

FDA Removes Age Restriction for Neffy Nasal Spray

Many Plant Foods Without Allergen Labels Pose Severe Risk

Related Posts

HHS Panel That Aims to Reshape U.S. Healthcare Holds Its First Meeting

CDC Places Limits on U.S. Entry as Deaths Top 100 in Ebola Outbreak

Leucovorin Scripts Surged Even Before White House Autism Push

American Doctor Has Ebola, Will Be Transferred for Care

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Drowning Prevention Is a Team Effort, Pediatricians Say

HHS Panel That Aims to Reshape U.S. Healthcare Holds Its First Meeting

CDC Places Limits on U.S. Entry as Deaths Top 100 in Ebola Outbreak

Leucovorin Scripts Surged Even Before White House Autism Push

American Doctor Has Ebola, Will Be Transferred for Care

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Drowning Prevention Is a Team Effort, Pediatricians Say

FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients

Whole Blood Not Better Than Components En Route to Hospital After Traumatic Injury

Categories

Archives